Skip to main content

Advertisement

SpringerLink
Log in

A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress

  • Concise Communication
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Oxidative stress may play a pivotal role in the pathogenesis of psoriasis, an inflammatory/hyperproliferative skin disease characterized by the cutaneous accumulation of neutrophils releasing reactive oxygen species, as revealed in a number of studies. This study was performed to demonstrate the presence of oxidative stress in psoriasis, as measured by protein oxidation markers. Twenty-nine psoriasis patients were selected based on disease severity assessment using body surface area as well as the psoriasis area severity index (PASI), and were grouped as mild (PASI ≤ 10) and moderate-to-severe (PASI > 10). The measured parameters in psoriatic patients and fourteen healthy volunteers were as follows: erythrocyte sedimentation rate (ESR), high sensitive C-reactive protein (CRP), myeloperoxidase (MPO) activity, neopterin, total lipid hydroperoxides (LHP), pyrrolized protein (PP), protein carbonyl compounds (PCC), advanced oxidation protein products (AOPP), thiol levels, along with complete blood count. Except lower thiols, all parameters were found to be higher in total patients as well as in subgroups, compared to controls. There was no significant difference among the subgroups. In conclusion, protein oxidation in psoriatics, not only in moderate-to-severe, but also in mild patients, may be explained by the findings of inflammation, phagocytic cell oxidation, and MPO-hypochlorous acid-oxidation reactions; as reflected by increased total/differential leucocytes counts, CRP, ESR as well as MPO, neopterin, AOPP, PCC, PP, LHP, and decreased thiol levels. Demonstrating the AOPP and PP formation for the first time, oxidants from active neutrophils/monocytes may play an important role in the pathogenesis of psoriasis, leading to oxidative stress, especially by protein oxidation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bacchetti T, Campanati A, Ferretti G et al (2013) Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment. Br J Dermatol 168:984–989

    Article  CAS  PubMed  Google Scholar 

  2. Baek J-O, Byamba D, Wu WH et al (2012) Assessment of an imiquimod-induced psoriatic mouse model in relation to oxidative stress. Arch Dermatol Res 304:699–706

    Article  CAS  PubMed  Google Scholar 

  3. Barygina VV, Becatti M, Soldi G et al (2013) Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy. Redox Rep 18:100–106

    Article  CAS  PubMed  Google Scholar 

  4. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–209

    Article  CAS  PubMed  Google Scholar 

  5. Briganti S, Picardo M (2003) Antioxidant activity, lipid peroxidation and skin diseases. What’s new. J Eur Acad Dermatol Venereol 17:663–669

    Article  CAS  PubMed  Google Scholar 

  6. Cao LY, Soler DC, Debanne SM et al (2013) Psoriasis and cardiovascular risk factors: increased serum myeloperoxidase and corresponding immunocellular overexpression by Cd11b(+) CD68(+) macrophages in skin lesions. Am J Transl Res 6:16–27

    PubMed  PubMed Central  Google Scholar 

  7. Coimbra S, Oliveira H, Reis F et al (2010) C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy. J Eur Acad Dermatol Venereol 24:789–796

    Article  CAS  PubMed  Google Scholar 

  8. Dalle-Donne I, Rossi R, Giustarini D et al (2003) Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23–38

    Article  CAS  PubMed  Google Scholar 

  9. Damasiewicz-Bodzek A, Wielkoszyński T (2012) Advanced protein glycation in psoriasis. J Eur Acad Dermatol Venereol 26:172–179

    Article  CAS  PubMed  Google Scholar 

  10. Davies MJ (2011) Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr 48:8–19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Dimon-Gadal S, Gerbaud P, Thérond P et al (2000) Increased oxidative damage to fibroblasts in skin with and without lesions in psoriasis. J Invest Dermatol 114:984–989

    Article  CAS  PubMed  Google Scholar 

  12. Doğan P, Soyuer U, Tanrikulu G (1989) Superoxide dismutase and myeloperoxidase activity in polymorphonuclear leukocytes, and serum ceruloplasmin and copper levels, in psoriasis. Br J Dermatol 120:239–244

    PubMed  Google Scholar 

  13. Ferretti G, Bacchetti T, Campanati A et al (2012) Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1. Br J Dermatol 166:204–207

    Article  CAS  PubMed  Google Scholar 

  14. Hidalgo FJ, Alaiz M, Zamora R (1998) A spectrophotometric method for the determination of proteins damaged by oxidized lipids. Anal Biochem 262:129–136

    Article  CAS  PubMed  Google Scholar 

  15. Himmelfarb J, McMonagle E, McMenamin E (2000) Plasma protein thiol oxidation and carbonyl formation in chronic renal failure. Kidney Int 58:2571–2578

    Article  CAS  PubMed  Google Scholar 

  16. Hoffmann G, Schobersberger W (2013) Neopterin: a mediator of the cellular immune system. Pteridines 15:107–112

    Google Scholar 

  17. Hu ML, Louie S, Cross CE et al (1993) Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 121:257–262

    CAS  PubMed  Google Scholar 

  18. Ibrahimbaş Y, Polat M, Serin E, Parlak AH (2010) Cellular immune response in patients with chronic plaque type psoriasis: evaluation of serum neopterin, procalcitonin, anti-streptolysin O and C reactive protein levels. J Clin Exp Dermatol Res 1:107. doi:10.4172/2155-9554.1000107

    Google Scholar 

  19. Iwai I, Shimadzu K, Kobayashi Y et al (2010) Increased carbonyl protein level in the stratum corneum of inflammatory skin disorders: a non-invasive approach. J Dermatol 37:693–698

    Article  PubMed  Google Scholar 

  20. Kanelleas A, Liapi C, Katoulis A et al (2011) The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept. Clin Exp Dermatol 36:845–850

    Article  CAS  PubMed  Google Scholar 

  21. Kapuścińska R, Wysocka J, Niczyporuk W, Ratomski K (2004) Cytofluorimetric assay for evaluation of CD16 receptor expression and myeloperoxidase (MPO) activity of neutrophils in patients with psoriasis vulgaris treated with PUVA. Wiad Lek 57:599–602

    PubMed  Google Scholar 

  22. Kaur S, Zilmer K, Leping V, Zilmer M (2013) Serum methylglyoxal level and its association with oxidative stress and disease severity in patients with psoriasis. Arch Dermatol Res 305:489–494

    Article  CAS  PubMed  Google Scholar 

  23. Martínez-Cruz F, Guerrero JM, Osuna C (2002) Melatonin prevents the formation of pyrrolized proteins in human plasma induced by hydrogen peroxide. Neurosci Lett 326:147–150

    Article  PubMed  Google Scholar 

  24. Nourooz-Zadeh J (1999) Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol 300:58–62

    Article  CAS  PubMed  Google Scholar 

  25. Orem A, Değer O, Cimşit G, Bahadir S (1997) Plasma polymorphonuclear leukocyte elastase levels and its relation to disease activity in psoriasis. Clin Chim Acta 264:49–56

    Article  CAS  PubMed  Google Scholar 

  26. Piwowar A (2010) Advanced oxidation protein products. Part I. Mechanism of the formation, characteristics and property. Pol Merkur Lekarski 28:166–169

    CAS  PubMed  Google Scholar 

  27. Relhan V, Gupta SK, Dayal S et al (2002) Blood thiols and malondialdehyde levels in psoriasis. J Dermatol 29:399–403

    Article  CAS  PubMed  Google Scholar 

  28. Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–363

    Article  CAS  PubMed  Google Scholar 

  29. Rocha-Pereira P, Santos-Silva A, Rebelo I et al (2004) The inflammatory response in mild and in severe psoriasis. Br J Dermatol 150:917–928

    Article  CAS  PubMed  Google Scholar 

  30. Salomon RG, Kaur K, Podrez E et al (2000) HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaques. Chem Res Toxicol 13:557–564

    Article  CAS  PubMed  Google Scholar 

  31. Sánchez-Regaña M, Catasús M, Creus L, Umbert P (2000) Serum neopterin as an objective marker of psoriatic disease activity. Acta Derm Venereol 80:185–187

    Article  PubMed  Google Scholar 

  32. Severin E, Nave B, Ständer M et al (1999) Total antioxidative capacity is normal in sera from psoriasis patients despite elevated bilirubin, tocopherol and urate levels. Dermatology (Basel) 198:336–339

    Article  CAS  Google Scholar 

  33. Shah AA, Sinha AA (2013) Oxidative stress and autoimmune skin disease. Eur J Dermatol 23:5–13

    CAS  PubMed  Google Scholar 

  34. Suji G, Sivakami S (2008) Malondialdehyde, a lipid-derived aldehyde alters the reactivity of Cys34 and the esterase activity of serum albumin. Toxicol In Vitro 22:618–624

    Article  CAS  PubMed  Google Scholar 

  35. Wagener FADTG, Carels CE, Lundvig DMS (2013) Targeting the redox balance in inflammatory skin conditions. Int J Mol Sci 14:9126–9167

    Article  PubMed  PubMed Central  Google Scholar 

  36. Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Research Fund of the University of Erciyes (Grant No. TA-05-14).

Author information

Authors and Affiliations

  1. Department of Biochemistry, Faculty of Medicine, Erciyes University, 38039, Kayseri, Turkey

    Cevat Yazici, Kader Köse & Esen Tanrikulu

  2. Department of Dermatology, Faculty of Medicine, Erciyes University, 38039, Kayseri, Turkey

    Serap Utaş & Nazan Taşlidere

Authors
  1. Cevat Yazici
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kader Köse
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Serap Utaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Esen Tanrikulu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nazan Taşlidere
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cevat Yazici.

Ethics declarations

Conflict of interest

The authors report no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yazici, C., Köse, K., Utaş, S. et al. A novel approach in psoriasis: first usage of known protein oxidation markers to prove oxidative stress. Arch Dermatol Res 308, 207–212 (2016). https://doi.org/10.1007/s00403-016-1624-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-016-1624-0

Keywords

Search

Navigation